China BCT Pharmacy Group Inc
China BCT Pharmacy Group, Inc., through its subsidiaries, operates as an integrated pharmaceutical company in the People's Republic of China. It operates through three segments: Pharmaceutical Distribution, Retail Pharmacy, and Manufacturing Pharmacy. The Pharmaceutical Distribution segment purchases pharmaceutical products from suppliers and distributes them to hospitals, retail drug stores, oth… Read more
China BCT Pharmacy Group Inc (CNBI) - Total Liabilities
Latest total liabilities as of June 2013: $114.83 Million USD
Based on the latest financial reports, China BCT Pharmacy Group Inc (CNBI) has total liabilities worth $114.83 Million USD as of June 2013.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
China BCT Pharmacy Group Inc - Total Liabilities Trend (2007–2012)
This chart illustrates how China BCT Pharmacy Group Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
China BCT Pharmacy Group Inc Competitors by Total Liabilities
The table below lists competitors of China BCT Pharmacy Group Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Consolidated Eco-Systems Inc
PINK:EXSO
|
USA | $21.88 Million |
|
Ormet Corporation
PINK:ORMTQ
|
USA | $384.77 Million |
|
Compliance Energy Corporation
OTCGREY:CPYCF
|
USA | $1.06 Million |
|
US BioTec Inc
PINK:USBC
|
USA | $588.16K |
|
Piksel Inc
PINK:PIKL
|
USA | $146.85 Million |
|
New Frontier Energy Inc
PINK:NFEI
|
USA | $108.08K |
|
Rainforest Resources Inc
OTCQB:RRIF
|
USA | $8.73 Million |
|
Supurva Healthcare Group Inc
PINK:SPRV
|
USA | $3.06 Million |
Liability Composition Analysis (2007–2012)
This chart breaks down China BCT Pharmacy Group Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.17 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.79 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how China BCT Pharmacy Group Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for China BCT Pharmacy Group Inc (2007–2012)
The table below shows the annual total liabilities of China BCT Pharmacy Group Inc from 2007 to 2012.
| Year | Total Liabilities | Change |
|---|---|---|
| 2012-12-31 | $110.71 Million | +15.25% |
| 2011-12-31 | $96.06 Million | +64.37% |
| 2010-12-31 | $58.44 Million | +47.27% |
| 2009-12-31 | $39.68 Million | +2645398.87% |
| 2008-12-31 | $1.50K | -75.00% |
| 2007-12-31 | $6.00K | -- |